Shelton Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-3,429
| Closed | -$587K | – | 844 |
|
|
2018
Q3 | $587K | Buy |
3,429
+281
| +9% | +$48.1K | 0.03% | 318 |
|
|
2018
Q2 | $407K | Hold |
3,148
| – | – | 0.03% | 421 |
|
|
2018
Q1 | $324K | Buy |
3,148
+416
| +15% | +$42.8K | 0.02% | 516 |
|
|
2017
Q4 | $233K | Hold |
2,732
| – | – | 0.02% | 730 |
|
|
2017
Q3 | $232K | Sell |
2,732
-290
| -10% | -$24.6K | 0.02% | 713 |
|
|
2017
Q2 | $229K | Buy |
+3,022
| New | +$229K | 0.02% | 750 |
|